从1990年到2046年,非酒精性脂肪肝疾病的全球负担:使用GBD 2021数据进行基于全球人口的观察趋势分析
Guiming Chen1, Yanming Sha2, Ying Xiao3
1Interventional Medicine Department, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Medicine
|February 24, 2026
概括
由于人口增长和生活方式的变化,非酒精性脂肪性肝病 (NAFLD) 的发病率和负担在全球显著增加. 患病率和死亡率的差异正在扩大,特别是在中级SDI国家.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 全球卫生流行病学
- 公共卫生 公共卫生
背景情况:
- 非酒精性脂肪性肝病 (NAFLD),现在是与代谢功能障碍相关的脂肪性肝病,影响全球25%的人口.
- 肥胖和生活方式的改变是主要的驱动因素,给公共卫生和经济带来了巨大的负担.
- 在NAFLD的全球影响方面,日益扩大的健康差异是越来越令人担忧的.
研究的目的:
- 从1990年到2021年分析NAFLD的全球发病率,流行率,死亡率和DALYs.
- 调查地理模式,社会人口统计指数 (SDI) 相关性和时间趋势.
- 预测未来的NAFLD负担并分析健康不平等.
主要方法:
- 利用了2021年全球疾病负担研究的数据.
- 分析了SDI五分位数,地区和国家的趋势.
- 雇员年龄时期队列建模,分解和健康不平等分析,预测到2046年.
主要成果:
- 从1990年到2021年,全球NAFLD负担大幅增加,发病率上升1.95倍.
- 人口增长和流行病学转变是增加发病率的关键驱动因素.
- 在中等SDI国家和特定高负担地区,负担最高,差距越来越大.
结论:
- 纳氏肺炎是一种普遍存在的全球健康挑战,其负担显著且日益增加.
- 在NAFLD患病率,死亡率和DALY方面,地理和社会人口差异正在扩大.
- 有针对性的预防和干预策略至关重要,特别是对于中等SDI设置和高负担地区.
相关概念视频
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
243
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
243
Ultrasound II: Endoscopic Ultrasound and FibroScan
839
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
839


